Matarin Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-47,508
| Closed | -$2.02M | – | 218 |
|
|
2020
Q3 | $2.02M | Sell |
47,508
-11,469
| -19% | -$487K | 0.42% | 103 |
|
|
2020
Q2 | $2.83M | Sell |
58,977
-29,296
| -33% | -$1.41M | 0.56% | 82 |
|
|
2020
Q1 | $4.06M | Sell |
88,273
-81,735
| -48% | -$3.76M | 0.63% | 70 |
|
|
2019
Q4 | $10.2M | Sell |
170,008
-74,687
| -31% | -$4.49M | 0.98% | 17 |
|
|
2019
Q3 | $13.8M | Buy |
244,695
+42,043
| +21% | +$2.38M | 1.05% | 13 |
|
|
2019
Q2 | $11.3M | Buy |
202,652
+73,707
| +57% | +$4.1M | 0.81% | 45 |
|
|
2019
Q1 | $6.51M | Sell |
128,945
-6,609
| -5% | -$334K | 0.47% | 80 |
|
|
2018
Q4 | $5.46M | Buy |
135,554
+18,190
| +15% | +$733K | 0.44% | 79 |
|
|
2018
Q3 | $8.14M | Buy |
117,364
+97,281
| +484% | +$6.74M | 0.52% | 75 |
|
|
2018
Q2 | $1.52M | Buy |
20,083
+16,128
| +408% | +$1.22M | 0.11% | 183 |
|
|
2018
Q1 | $208K | Buy |
+3,955
| New | +$208K | 0.02% | 285 |
|
|
2017
Q3 | – | Sell |
-103,444
| Closed | -$8.16M | – | 306 |
|
|
2017
Q2 | $8.16M | Buy |
+103,444
| New | +$8.16M | 0.76% | 45 |
|
|
2016
Q1 | – | Sell |
-3,221
| Closed | -$286K | – | 246 |
|
|
2015
Q4 | $286K | Buy |
+3,221
| New | +$286K | 0.04% | 205 |
|